IFP Advisors
HRMY icon

IFP Advisors’s Harmony Biosciences HRMY Stock Holding History

IFP Advisors’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$330K Buy
8,399
+297
+4% +$11.5K 0.01% 1258
2026
Q2 		$295K Buy
8,102
+353
+5% +$11.1K 0.01% 1296
2026
Q1 		$217K Buy
7,749
+330
+4% +$10.8K ﹤0.01% 1349
2025
Q4 		$278K Buy
7,419
+926
+14% +$30.4K 0.01% 1203
2025
Q3 		$179K Sell
6,493
-193
-3% -$6.65K ﹤0.01% 1342
2025
Q2 		$211K Buy
6,686
+2,080
+45% +$66.9K 0.01% 1250
2025
Q1 		$153K Buy
4,606
+4,600
+76,667% +$165K ﹤0.01% 1302
2024
Q4 		$206 Buy
+6
New +$206 ﹤0.01% 3727
2023
Q4 		– Sell
-25
Closed -$819 – 3187
2023
Q3 		$819 Hold
25
– – ﹤0.01% 3039
2023
Q2 		$880 Hold
25
– – ﹤0.01% 3107
2023
Q1 		$925 Sell
25
-363
-94% -$16.5K ﹤0.01% 3093
2022
Q4 		$21K Sell
388
-611
-61% -$33.6K ﹤0.01% 2847
2022
Q3 		$45K Buy
999
+332
+50% +$16.2K ﹤0.01% 2444
2022
Q2 		$32K Hold
667
– – ﹤0.01% 2482
2022
Q1 		$32K Buy
+667
New +$27.2K ﹤0.01% 2480

Other funds holding HRMY

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $668M AUM 8.93% 1-Year Est. Return
Bridge City Capital
Bridge City Capital Lake Oswego, Oregon $480M AUM 47.16% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
CX Institutional
CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return

IFP Advisors's HRMY Position: Q3 2026 in Review

IFP Advisors increased its Harmony Biosciences (HRMY) stake by 3.7% in Q3 2026, buying an estimated $11.5K and bringing the position to 8,399 shares worth $330K. The position accounts for 0.01% of the portfolio, ranked #1258.

IFP Advisors first reported a position in HRMY in Q1 2022 and has held it in 15 quarters since. 141 funds tracked by Wall St. Rank hold HRMY as of Q3 2026.

  • IFP Advisors held 8,399 shares of Harmony Biosciences worth $330K as of Q3 2026.
  • IFP Advisors bought 297 Harmony Biosciences shares in Q3 2026, an estimated $11.5K.
  • Harmony Biosciences made up 0.01% of IFP Advisors's portfolio in Q3 2026, its #1258 holding.
  • IFP Advisors first reported a position in Harmony Biosciences in Q1 2022 and has held it in 15 quarters since.
  • 141 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.